FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023595092> ?p ?o ?g. }

• W2023595092 endingPage "341" @default.
• W2023595092 startingPage "335" @default.
• W2023595092 abstract "Our objective was to construct a recombinant bacillus Calmette-Guérin vaccine (rBCG) that secretes human interferon-alpha 2b (IFNα-2b) and to study its immunogenicity and in vitro antitumor activity against human bladder cancer cell lines T24 and T5637. The signal sequence BCG Ag85B and the gene IFNα-2b were amplified from the genome of BCG and human peripheral blood, respectively, by polymerase chain reaction (PCR). The two genes were cloned in Escherichia coli-BCG shuttle-vector pMV261 to obtain a new recombinant plasmid pMV261-Ag85B-IFNα-2b. BCG was transformed with the recombinant plasmid by electroporation and designated rBCG-IFNα-2b. Mononuclear cells were isolated from human peripheral blood (PBMCs) and stimulated with rBCG-IFNα-2b or wild type BCG for 3 d, and then cultured with human bladder cancer cell lines T24 and T5637. Their cytotoxicities were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. BCG was successfully transformed with the recombinant plasmid pMV261-Ag85B-IFNα-2b by electroporation and the recombinant BCG (rBCG-IFNα-2b) was capable of synthesizing and secreting cytokine IFNα-2b. PBMC proliferation was enhanced significantly by rBCG-IFNα-2b, and the cytotoxicity of PBMCs stimulated by rBCG-IFNα-2b to T24 and T5627 was significantly stronger in comparison to wild type BCG. A recombinant BCG, secreting human IFNα-2b (rBCG-IFNα-2b), was constructed successfully and was superior to control wild type BCG in inducing immune responses and enhancing cytotoxicity to human bladder cancer cell lines T24 and T5637. This suggests that rBCG-IFNα-2b could be a promising agent for bladder cancer patients in terms of possible reductions in both clinical dosage and side effects of BCG immunotherapy." @default.
• W2023595092 created "2016-06-24" @default.
• W2023595092 creator A5010776860 @default.
• W2023595092 creator A5022585660 @default.
• W2023595092 creator A5040626069 @default.
• W2023595092 creator A5050239493 @default.
• W2023595092 creator A5059519440 @default.
• W2023595092 creator A5065650650 @default.
• W2023595092 creator A5091538633 @default.
• W2023595092 date "2012-05-01" @default.
• W2023595092 modified "2023-10-13" @default.
• W2023595092 title "Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells" @default.
• W2023595092 cites W1576095056 @default.
• W2023595092 cites W1589548603 @default.
• W2023595092 cites W1929489495 @default.
• W2023595092 cites W1966147407 @default.
• W2023595092 cites W1971130377 @default.
• W2023595092 cites W1982967111 @default.
• W2023595092 cites W1989494569 @default.
• W2023595092 cites W1996535081 @default.
• W2023595092 cites W2000866407 @default.
• W2023595092 cites W2001997364 @default.
• W2023595092 cites W2011652598 @default.
• W2023595092 cites W2012047334 @default.
• W2023595092 cites W2018639984 @default.
• W2023595092 cites W2030238108 @default.
• W2023595092 cites W2039919489 @default.
• W2023595092 cites W2040044724 @default.
• W2023595092 cites W2045188044 @default.
• W2023595092 cites W2049281176 @default.
• W2023595092 cites W2082369230 @default.
• W2023595092 cites W2082632361 @default.
• W2023595092 cites W2099982247 @default.
• W2023595092 cites W2112968705 @default.
• W2023595092 cites W2124229226 @default.
• W2023595092 cites W2134242142 @default.
• W2023595092 cites W2134589781 @default.
• W2023595092 cites W2153412942 @default.
• W2023595092 cites W2165509526 @default.
• W2023595092 cites W2414377436 @default.
• W2023595092 cites W4243650202 @default.
• W2023595092 cites W4302588583 @default.
• W2023595092 cites W4313347689 @default.
• W2023595092 doi "https://doi.org/10.1631/jzus.b1100366" @default.
• W2023595092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3348223" @default.
• W2023595092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22556170" @default.
• W2023595092 hasPublicationYear "2012" @default.
• W2023595092 type Work @default.
• W2023595092 sameAs 2023595092 @default.
• W2023595092 citedByCount "12" @default.
• W2023595092 countsByYear W20235950922012 @default.
• W2023595092 countsByYear W20235950922013 @default.
• W2023595092 countsByYear W20235950922014 @default.
• W2023595092 countsByYear W20235950922015 @default.
• W2023595092 countsByYear W20235950922016 @default.
• W2023595092 countsByYear W20235950922020 @default.
• W2023595092 countsByYear W20235950922022 @default.
• W2023595092 crossrefType "journal-article" @default.
• W2023595092 hasAuthorship W2023595092A5010776860 @default.
• W2023595092 hasAuthorship W2023595092A5022585660 @default.
• W2023595092 hasAuthorship W2023595092A5040626069 @default.
• W2023595092 hasAuthorship W2023595092A5050239493 @default.
• W2023595092 hasAuthorship W2023595092A5059519440 @default.
• W2023595092 hasAuthorship W2023595092A5065650650 @default.
• W2023595092 hasAuthorship W2023595092A5091538633 @default.
• W2023595092 hasBestOaLocation W20235950922 @default.
• W2023595092 hasConcept C104317684 @default.
• W2023595092 hasConcept C137061746 @default.
• W2023595092 hasConcept C153911025 @default.
• W2023595092 hasConcept C159047783 @default.
• W2023595092 hasConcept C186852380 @default.
• W2023595092 hasConcept C202751555 @default.
• W2023595092 hasConcept C203014093 @default.
• W2023595092 hasConcept C22744801 @default.
• W2023595092 hasConcept C2776178377 @default.
• W2023595092 hasConcept C2778690821 @default.
• W2023595092 hasConcept C2780841837 @default.
• W2023595092 hasConcept C2780868878 @default.
• W2023595092 hasConcept C40767141 @default.
• W2023595092 hasConcept C55493867 @default.
• W2023595092 hasConcept C86803240 @default.
• W2023595092 hasConcept C8891405 @default.
• W2023595092 hasConcept C89423630 @default.
• W2023595092 hasConceptScore W2023595092C104317684 @default.
• W2023595092 hasConceptScore W2023595092C137061746 @default.
• W2023595092 hasConceptScore W2023595092C153911025 @default.
• W2023595092 hasConceptScore W2023595092C159047783 @default.
• W2023595092 hasConceptScore W2023595092C186852380 @default.
• W2023595092 hasConceptScore W2023595092C202751555 @default.
• W2023595092 hasConceptScore W2023595092C203014093 @default.
• W2023595092 hasConceptScore W2023595092C22744801 @default.
• W2023595092 hasConceptScore W2023595092C2776178377 @default.
• W2023595092 hasConceptScore W2023595092C2778690821 @default.
• W2023595092 hasConceptScore W2023595092C2780841837 @default.
• W2023595092 hasConceptScore W2023595092C2780868878 @default.
• W2023595092 hasConceptScore W2023595092C40767141 @default.
• W2023595092 hasConceptScore W2023595092C55493867 @default.
• W2023595092 hasConceptScore W2023595092C86803240 @default.

• next